HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia

Basit Öğe Kaydı
dc.contributor.authorDayan, Saim
dc.contributor.authorTekin, Alicem
dc.contributor.authorTekin, Recep
dc.contributor.authorDal, Tuba
dc.contributor.authorHosoglu, Salih
dc.contributor.authorYazgan, Umit Can
dc.contributor.authorBekcibasi, Muhammed
dc.date.accessioned2024-04-24T17:20:59Z
dc.date.available2024-04-24T17:20:59Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroduction: This study investigated the seroprevalence of hepatitis B virus surface antigen (HBsAg), antibody against hepatitis C virus (anti-HCV), antibody against human immunodeficiency virus type 1/2 (anti-HIV 1/2), and antibody against Treponema pallidum (anti-Treponemal or syphilis antibody) in healthy volunteer blood donors, and assessed their distribution according to the years and genders. Methodology: HBsAg, anti-HCV, anti-HIV, and syphilis screening results of a total of 266,035 healthy volunteer blood donors who had been admitted for blood donation to the Regional Blood Center of Dicle University Hospital between January 2000 and December 2010 were evaluated, retrospectively. HBsAg, anti-HCV, and anti-HIV 1/2 screening were performed using a fully automated device with the microparticle enzyme immunoassay method (MEIA). Syphilis screening was performed by Rapid Plasma Reagin (RPR) carbon test between January 2000 and December 2009, and by using a fully automated device with the MEIA method between January 2010 and December 2010. Results: Of 266,035 healthy volunteer blood donors, 259,384 (97.5%) were male and 6,651 (2.5%) were female. Statistically, there was not any significant difference between male and female genders for HBsAg, anti-HCV and syphilis seropositivities (P = 0.729, P = 0.748, and P = 0.861, respectively). HBsAg was found to be positive in 8,422 (3.17%), anti-HCV in 1,703 (0.64%), anti-HIV 1/2 in one (0.0004%) of 266,035 healthy volunteer blood donors, and syphilis antibody with RPR in 166 (0.07%) of 246,341 healthy volunteer blood donors. Conclusion: Blood donor forms should be carefully tailored to improve the identification of possible risks of transfusion-transmitted infections.en_US
dc.identifier.doi10.3855/jidc.2835
dc.identifier.endpage669en_US
dc.identifier.issn1972-2680
dc.identifier.issue9en_US
dc.identifier.pmid24042102
dc.identifier.scopus2-s2.0-84884217041
dc.identifier.scopusqualityQ2
dc.identifier.startpage665en_US
dc.identifier.urihttps://doi.org/10.3855/jidc.2835
dc.identifier.urihttps://hdl.handle.net/11468/19325
dc.identifier.volume7en_US
dc.identifier.wosWOS:000324543100004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherJ Infection Developing Countriesen_US
dc.relation.ispartofJournal of Infection in Developing Countries
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBlood Transfusionen_US
dc.subjectBlood Donorsen_US
dc.subjectHepatitis B Surface Antigensen_US
dc.subjectHepatitis C Antibodiesen_US
dc.subjectHiv Seropositivityen_US
dc.subjectSyphilisen_US
dc.titleHBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatoliaen_US
dc.titleHBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu